Introduction
============

Since the early 1990s there has been a steady increase in prescription rates for opiates (Substance Abuse and Mental Health Services Administration \[SAMHSA\], [@B78]), including prescribing for conditions ranging from routine dental procedures to menstrual cramps. This escalation in prescribing, coupled with increased availability of these substances online (Forman et al., [@B27]), and the advent of long-acting forms of opiate analgesics such as OxyContin®, have combined to create a dangerous upsurge in both the medical and non-medical use of prescription pain medications (Paulozzi et al., [@B63]; Cai et al., [@B12]). Of great concern is the increased use of these potent opiates in adolescent populations (Sung et al., [@B80]), with 60.6% of respondents in a recent survey reporting initiation of use before the age of 15 (Wu et al., [@B96]). Misuse in younger populations is likely due to the decreased risk perception associated with prescription opiates (e.g., as compared to heroin), in conjunction with their increased availability. Indeed, overall, prescription drugs are reported as the "drug of choice" in 12- and 13-year-old populations (SAMHSA, [@B77]) and unlike other drugs of abuse, they are used at higher rates in young female populations (Sung et al., [@B80]; Alemagno et al., [@B1]). Currently, the long-term impact of this increased use of opiates in adolescent female populations remains unknown.

Given that adolescence represents a period of significant brain maturation, perturbation of the endogenous opioid system during this period may induce significant long-term effects. Endogenous opioids (beta-endorphin, dynorphin, and enkephalin) and their receptor targets (mu, kappa, and delta) are ubiquitous, serving as critical modulators of neural, endocrine, and immune function. For example, during adolescence, endogenous opioids modulate the timing of sexual maturation (Cicero et al., [@B19]; Reiter, [@B65]; Sizonenko, [@B71]). Opioids also regulate stress responsiveness as well as modulating numerous cognitive and reward-related processes (Zager and Black, [@B97]; McCubbin, [@B51]; Van Ree et al., [@B88]; Drolet et al., [@B25]; Kreek, [@B43]). Thus, adaptations in response to high levels of opioids during adolescent development could impact a wide-range of opioid-mediated functions.

A significant body of literature indicates that endogenous opioids play a role in maternal behavior. Initial studies conducted with morphine, showed a disruption of postpartum maternal behavior (Bridges and Grimm, [@B6]; Rubin and Bridges, [@B67]; Kinsley and Bridges, [@B39], [@B40]; Mann et al., [@B50]; Kinsley et al., [@B41]; Sukikara et al., [@B79]). These disruptive effects were even more pronounced when the female was pre-exposed to morphine during pregnancy (Bridges and Grimm, [@B6]; Miranda-Paiva et al., [@B55]; Slamberova et al., [@B74]). In a number of species, including humans and non-human primates, endogenous opioids modulate affiliative behaviors, including mother--infant attachment (Panksepp et al., [@B62]; Kalin et al., [@B36]; Nelson and Panksepp, [@B57]; Saltzman and Maestripieri, [@B68]). Indeed, there is evidence in women, that opioid use (e.g., methadone) can induce subtle alterations in mother--infant contact and attachment (Goodman et al., [@B30]). Moreover, studies indicate that endogenous opioids in both the mother, and the infant, are important for infant emotional regulation and attachment (Schino and Troisi, [@B69]; Weller and Feldman, [@B94]; Barr et al., [@B4]). If this system is altered by prior exposure to opiates, then postpartum maternal--offspring interactions could be affected.

We have previously documented significant effects of adolescent morphine exposure on the expression of opioid-related genes, including increased expression of mu- and kappa-opioid receptor genes and decreased expression of the proopiomelanocortin gene in the mediobasal hypothalamus (Byrnes, [@B9]). In addition, we observed attenuated suckling-stimulated prolactin secretion during early lactation in these females (Byrnes, [@B8], [@B9]). These findings demonstrate long-term changes in the endogenous opioid system of adolescent-exposed females, as well as alterations in physiological parameters that can influence maternal care. One additional component of these studies was an examination of rudimentary aspects of maternal behavior, such as the latency to retrieve and crouch over pups following a brief separation. No differences in maternal behavior latencies were observed, however, such measures do not assess quantitative or qualitative aspects of maternal care.

In addition to observing direct effects of adolescent morphine exposure on the female rat, we have also demonstrated transgenerational effects in both male and female offspring. These offspring effects include differences in anxiety-like behavior, shifts in morphine sensitization and alterations in morphine analgesia (Byrnes, [@B7]; Byrnes et al., [@B11]). It is important to note that all adolescent-exposed females in our studies are drug-free for several weeks prior to mating. Thus, the developing embryo/fetus is never directly exposed to morphine. These findings indicate that even when morphine exposure is confined to the adolescent period, there can be significant effects on future offspring. Moreover, the nature of these transgenerational effects suggests an alteration in the endogenous opioid system of the offspring. Variations in maternal care can significantly impact offspring neurodevelopment, including the development of the endogenous opioid system (Weaver et al., [@B93]; Gustafsson et al., [@B33]; Michaels and Holtzman, [@B54]). Thus, one potential mechanism underlying transgenerational effects of adolescent morphine exposure may be altered maternal--offspring interactions.

The current study was designed to examine maternal behavior in females exposed to morphine during adolescent development. In addition, we also investigated social play behavior in their male and female offspring. The choice of social play behavior was based upon studies indicating that play behavior is modulated by opioids (Niesink and Van Ree, [@B59]; Vanderschuren et al., [@B87]; Van den Berg et al., [@B86]) and can be altered by changes in the postnatal environment (Janus, [@B35]; Veenema and Neumann, [@B91]). Our working hypothesis is that adolescent morphine exposure induces significant changes in the endogenous opioid system of both the female and her offspring.

Materials and Methods
=====================

Experimental animals
--------------------

Sixty female Sprague-Dawley rats (22 days of age) were purchased from Charles River Breeding Laboratories \[Crl:CD(SD)BR; Kingston, NY, USA\]. All animals were group-housed in light- (on 0700--1900 hours) and temperature- (21--24°C) controlled rooms and provided with food and water *ad libitum*. All animals were maintained in accordance with the National Research Council (NRC) Guide for the Care and Use of Laboratory Animals and all procedures were approved by the Institutional Animals Care and Use Committee of Tufts University.

Adolescent morphine exposure
----------------------------

Beginning at 30 days of age, females were treated with morphine (morphine sulfate; Butler-Schein, Dublin, OH, USA) for a total of 10 days using an increasing dose regimen. The doses used in the current study were based on allometric scaling to approximate human use (Chiou et al., [@B18]). Moreover, the use of increasing doses is more compatible with human use patterns, allowing for rising and falling levels of opiates. On day 1 of exposure, 30 animals received 5 mg/kg morphine sulfate (s.c.) once daily (between 0900 and 1100 hours). Every other day, the dose of morphine was increased by 5 mg/kg such that by the final day of treatment subjects received 25 mg/kg. Thirty, age-matched control animals received the saline vehicle (0.9% NaCl, s.c.) with volumes adjusted to match those of drug-treated females. Bodyweights were recorded daily throughout the treatment. Bodyweight gain during drug exposure was calculated by subtracting each animal\'s bodyweight on exposure day 1 from their bodyweight on exposure day 10. Bodyweight gain was also measured at additional time points post-withdrawal (1, 2, 12, and 19 days after withdrawal). Again, bodyweight gain was calculated relative to exposure day 1 (i.e., prior to their first injection). Adolescent-exposed females will subsequently be referred to as SAL-F0 and MOR-F0 females.

Mating and maternal behavior observations -- F0 females
-------------------------------------------------------

At 60 days of age (i.e., 3 weeks after their final injection), SAL-F0 and MOR-F0 females were mated with colony males. A total of 27 SAL-F0 and 28 MOR-F0 became pregnant. The day of parturition was designated as postnatal day 0 (PND0). On PND1 all litters were weighed and culled to 10 pups (five males: five females). In a subset of these females, home-cage maternal behavior was observed at multiple time points throughout PND4, PND10, and PND16. A behavioral checklist was used to monitor maternal behavior with frequencies recorded every 60 s during a 30-min observation period. A total of five observation periods per day were included; three during the light phase (0900, 1200, and 1500 hours), and two during the dark phase (0500 and 2000 hours). Behaviors monitored included nesting (in nest with pups regardless of nursing status), nursing (actively nursing at least one pup), pup grooming, and self-directed behaviors (eating, drinking, self-grooming). In addition, on PND5 and PPD12 maternal behavior was digitally recorded for 30 min during the light phase (0800 hours; 1 h after lights on) or the dark phase (2000 hour; 1 h after lights off). Maternal behavior durations were then scored. The behaviors included the following: nursing (arched back, side, or low posture), hovering (female is in the nest but no pups are nursing), pup grooming, and self-directed behavior. Care was taken to minimize any disturbance to mothers and litters during these home-cage observations. Sample sizes for frequency data were 15 SAL-F0 and 18 MOR-F0 mothers, sizes for the video analysis were 12 SAL-F0 and 10 MOR-F0 mothers.

Social play testing -- F1 males and females
-------------------------------------------

On PND21 all litters from F0 mothers were weighed and weaned. F1 male and female offspring were then group-housed with same sex siblings. Between PND24 and 26, SAL-F1 and MOR-F1 males and females were tested for social play behavior in a novel environment. Only one male and one female per litter were used in social play testing to eliminate potential litter effects. On the day of testing, animals were socially isolated in a holding cage for 3.5 h. Following isolation, unfamiliar subject pairs of the same sex and maternal adolescent exposure condition (i.e., SAL-F1 or MOR-F1) were placed in a novel test chamber (40 cm × 30 cm × 60 cm) under dim lighting conditions. Behavior was then digitally recorded for 15 min. Sample size was based on pairs, with each pair scored for the frequency and duration of select play behaviors using ODlog software. The scored behaviors included the following: boxing/wrestling, pinning, chasing/following, crawling over/under, social exploration (sniffing any part of the conspecific), and social grooming. Sample sizes were 10 SAL-F1 male and 10 SAL-F1 female pairs; 12 MOR-F1 male and 12 MOR-F1 female pairs. These subjects represent data from *N* = 20 SAL-F0 litters and *N* = 24 MOR-F0 litters.

Statistical analyses
--------------------

Differences in bodyweight gain during the morphine exposure regimen were analyzed using a Student\'s *t*-test. Post-withdrawal bodyweight gain was analyzed using a two-way repeated-measures ANOVA with day as the within subject factor and drug exposure (SAL or MOR) as the between-subject factor. Maternal behavior frequency data were analyzed using a two-way repeated-measures ANOVA with phase of the light cycle as the within subject factor and adolescent maternal exposure as the between-subject factor. Each postnatal day was analyzed separately. Social play behavior data was analyzed using a two-way ANOVA with sex and adolescent maternal exposure (SAL-F1 versus MOR-F1) as factors. All significant effects were followed by *post hoc* analyses using the Tukey\'s test. For all data, significance was designated as *p* \< 0.05.

Results
=======

Effects of adolescent morphine exposure on bodyweight
-----------------------------------------------------

All females continued to gain weight during the 10-day injection regimen (SAL-F0 = 51.8 ± 1.2 g; MOR-F0 = 43.8 ± 0.89 g), however, MOR-F0 females gained significantly less than SAL-F0 controls \[*t*~(58)~ = −5.43, *p* \< 0.001\]. Attenuated bodyweight gain continued to be observed when measured soon after drug-withdrawal, but these differences did not persist at later time points \[day × drug interaction; *F*~(3,179)~ = 4.5, *p* \< 0.01\]. As shown in Figure [1](#F1){ref-type="fig"}, MOR-F0 females had reduced weight gain on the first 2 days following withdrawal, however, by the 12th day post-withdrawal these differences were no longer observed. Prior to mating (i.e., 20 days post-withdrawal), all females were of similar weights.

![**Mean (±SEM) body weight gain (gram) following cessation of daily injections**. \**p* \< 0.001 as compared to SAL-F0 within day. *N* = 27 SAL-F0; *N* = 28 MOR-F0.](fpsyt-02-00029-g001){#F1}

Data recorded on PND1 did not reveal any significant differences in litter size, gender ratio, or total litter weight (all *p*s \> 0.2). At weaning (PND21) there was a significant difference between the groups, with MOR-F1 subjects weighing more than SAL-F1 controls \[*t*~(53)~ = 2.17, *p* \< 0.05\]. These data are reported in Table [1](#T1){ref-type="table"}. As post-culling bodyweights were not taken on PND1, we were unable to determine whether MOR-F1 pups that remained post-culling were heavier. Thus, whether these differences reflect increased bodyweight gain in MOR-F1 pups during the postnatal period remains to be determined.

###### 

**The effects of adolescent morphine exposure on postnatal parameters**.

           Litter size (no. of pups)   No. of females   No. of males   Bodyweight (g, PND1)   Bodyweight (g, PND21)
  -------- --------------------------- ---------------- -------------- ---------------------- ----------------------------------------------
  SAL-F0   14.1 ± 0.5                  6.7 ± 0.4        7.4 ± 0.4      91.2 ± 2.7             550.9 ± 8.8
  MOR-F0   14.2 ± 0.4                  7.5 ± 0.3        6.6 ± 0.5      96.5 ± 2.3             582.1 ± 11.0[\*](#tfn1){ref-type="table-fn"}

\**p* \< *0.05 as compared to SAL-F0 on PND21*.

Maternal behavior in adolescent morphine-exposed females -- frequencies
-----------------------------------------------------------------------

All maternal behavior frequency data are presented in Figure [2](#F2){ref-type="fig"}. On PND4, there was a main effect of light phase \[*F*~(1,31)~ = 55.4, *p* \< 0.001\], adolescent exposure \[*F*~(1,31)~ = 6.9, *p* \< 0.02\], as well as a significant interaction \[*F*~(1,31)~ = 4.3, *p* \< 0.05\] on the frequency of nursing behavior. Specifically, all females showed reduced nursing during the dark phase, however, MOR-F0 mothers nursed less frequently during the dark phase (*p* \< 0.01). On PND10 there was a main effect of light phase \[*F*~(1,31)~ = 11.0, *p* \< 0.001\], with no other significant effects. Finally, on PND16 there was both a main effect of light phase \[*F*~(1,31)~ = 9.4, *p* \< 0.01\] and a significant interaction \[*F*~(1,31)~ = 5.2, *p* \< 0.05\]. *Post hoc* analyses indicate that SAL-F0 mothers nursed less frequently during the dark phase, while MOR-F0 mothers did not reduce nursing frequency during the dark phase.

![**Mean (±SEM) frequency nursing, off nest, pup grooming, or engaged in self-directed behaviors on PND4, 10, and 16**. Data collected during the light phase was averaged across three observation periods (0900, 1200, and 1500 hours). Data collected during the dark phase was averaged across two observation periods (0500 and 2000 hours). ^\#^*p* \< 0.01 compared to light phase collapsed across maternal adolescent exposure condition. ^\#\#^*p* \< 0.05 compared to light phase within SAL-F0. \**p* \< 0.02 compared to SAL-F0 females within day. *N* = 15 SAL-F0; *N* = 18 MOR-F0.](fpsyt-02-00029-g002){#F2}

The decreased frequency of nursing observed in MOR-F0 was related to an increase in their frequency away from the nest. As shown in Figure [2](#F2){ref-type="fig"}, MOR-F0 mothers tended to be away from their nests more frequently than SAL-F0 mothers during the dark phase. On PND4, there was a main effect of light phase \[*F*~(1,31)~ = 71.2, *p* \< 0.001\] as well as a significant interaction \[*F*~(1,31)~ = 6.9, *p* \< 0.02\]. All females were off the nest more frequently during the dark, however, this effect was significantly greater in MOR-F0 mothers (*p* \< 0.01). On PND10 there was a main effect of both light phase \[*F*~(1,31)~ = 119.9, *p* \< 0.001\] and adolescent exposure \[*F*~(1,31)~ = 4.3, *p* \< 0.05\], with MOR-F0 off the nest more frequently than SAL-F0 mothers. Finally, on PND16 there was a main effect of light phase \[*F*~(1,31)~ = 30.86, *p* \< 0.001\] and a significant interaction \[*F*~(1,31)~ = 7.16, *p* \< 0.02\]. *Post hoc* analyses indicate an increased frequency for MOR-F0 mothers to be away from the nest when compared to SAL-F0 mothers during the light phase only.

As expected, the frequency of pup grooming decreased while self-directed behaviors increased in the dark phase when compared to the light phase. These effects were similar across all postnatal days examined (see Figure [2](#F2){ref-type="fig"}; main effect of light phase, all *p*s \< 0.05). No significant effects of adolescent morphine exposure were observed on frequency of pup grooming or self-directed behaviors, nor were there any significant interactions (all *p*s \> 0.1).

Maternal behavior in adolescent morphine-exposed females -- duration
--------------------------------------------------------------------

As illustrated in Figure [3](#F3){ref-type="fig"} (left panels), significant effects of both the light phase and maternal adolescent exposure were observed on PND5. All females nursed more during the light phase \[*F*~(1,19)~ = 8.21, *p* \< 0.05\], with no significant differences between MOR-F0 and SAL-F0 mothers (*p*s \> 0.6). However, when we examined the amount of time female\'s spent hovering over their litter (i.e., contacting but not actively nursing pups), there was a significant main effect of light phase \[*F*~(1,19)~ = 9.13, *p* \< 0.01\] and maternal adolescent exposure \[*F*~(1,19)~ = 8.93, *p* \< 0.01\]. Overall, MOR-F0 mothers spent more time hovering then SAL-F0 mothers. Finally, no significant effects on pup grooming were observed, while all females spent more time engaged in self-directed behaviors during the dark phase \[main effect of light phase; *F*~(1,19)~ = 17.4, *p* \< 0.01\].

![**Mean (±SEM) time (seconds) engaged in pup-directed and non-pup-directed activities on PND5 (left panels) and PND12 (right panels)**. Behavior was recorded at 0800 hours (light phase) and 2000 hours (dark phase). ^\#^*p* \< 0.01 as compared to light phase collapsed across adolescent exposure groups. \**p* \< 0.01 MOR-F0 compared to SAL-F0 collapsed across light cycle phase. *N* = 11 SAL-F0; *N* = 10 MOR-F0.](fpsyt-02-00029-g003){#F3}

Few statistically significant effects were observed on PND12, however, some interesting trends were observed (see Figure [3](#F3){ref-type="fig"}, right panels). For example, while no significant effects of light phase or maternal adolescent exposure on nursing behavior were observed (both *p*s \> 0.3), there was a trend \[*F*~(1,19)~ = 3.78, *p* = 0.067\] toward a light phase by maternal adolescent exposure interaction. This trend appears to be due to a tendency toward increased time spent nursing during the dark phase by MOR-F0 mothers. No significant effects on either hovering or pup grooming were observed. Finally, similar to the effects observed in PND5, all females engaged in more self-directed behaviors during the dark phase \[main effect of light phase; *F*~(1,19)~ = 5.12, *p* \< 0.05\].

Social play behavior in the offspring of adolescent morphine-exposed mothers
----------------------------------------------------------------------------

Frequency and duration data were combined from separate measures to form two categories of social play behavior. These categories were (1) general social behavior, which included both social exploration and social grooming, and (2) rough and tumble play, which included pinning, boxing, wrestling, chasing, following, crawling over/under, and tail pulling. These data are shown in Figure [4](#F4){ref-type="fig"}. There was no significant effect of either sex or maternal adolescent exposure on either the frequency or duration of general social behaviors, although there was a modest trend toward a main effect of sex on durations (*p* = 0.07). Maternal adolescent exposure did, however, significantly affect both the frequency and duration of rough and tumble play. Moreover, these effects were sex-specific with a significant sex by maternal adolescent exposure interaction \[frequency -- *F*~(1,43)~ = 4.89, *p* \< 0.05; duration -- *F*~(1,43)~ = 5.2, *p* \< 0.03\]. *Post hoc* analyses indicate that these effects were largely due to the decreased expression of rough and tumble play by MOR-F1 males (*p* \< 0.05). In addition to decreased play in MOR-F1 males, there was also a trend (*p* = 0.07) toward increased rough and tumble play in MOR-F1 females. Thus, significant sex differences were observed in MOR-F1 subjects (both *p*s \< 0.03), but not in SAL-F1 (both *p*s \> 0.3). Overall, these findings demonstrate a sex-specific shift in rough and tumble play in MOR-F1 subjects, which is not associated with alterations in other aspects of social behavior at this age.

![**Mean (±SEM) frequency and duration (seconds) of either general social behaviors (left panels) or rough and tumble play (right panels) in the offspring of females exposed to either morphine (MOR-F1) or saline (SAL-F1) during adolescence**. \**p* \< 0.05 as compared SAL-F1 males, ^τ^*p* \< 0.05 as compared to MOR-F1 males. *N* = 10 SAL-F1 male; *N* = 10 SAL-F1 female pairs and *N* = 12 MOR-F1 male; *N* = 12 MOR-F1 female pairs.](fpsyt-02-00029-g004){#F4}

Discussion
==========

The current findings demonstrate that exposure to escalating doses of morphine, confined to the adolescent period, can induce subtle modifications in subsequent maternal care and can alter the behavioral phenotype of subsequent offspring. These effects were largely expressed as differences in frequency of nursing and contact time during early lactation. In addition, the offspring of MOR-F0 mothers showed sex-specific differences in rough and tumble play. These results indicate that even when opiates are withdrawn several weeks prior to mating, a history of opiate exposure can influence both maternal care and offspring development.

A number of animal models have documented the effects of changes in maternal care on developing offspring. For example, the amount of licking and grooming that a female exhibits in the first week postpartum, can modify the behavioral phenotype of her offspring (Caldji et al., [@B13]). These offspring effects include shifts in the maternal behavior of adult female offspring (Champagne et al., [@B16]; Kikusui et al., [@B38]), as well as changes in stress responsiveness (Fish et al., [@B26]), play behavior (Moore and Power, [@B56]), and cognition (Liu et al., [@B48]; Champagne et al., [@B15]). Other models, focusing on the effects of either brief or prolonged maternal separation, have also illustrated the importance of mother--offspring interactions (D\'Amato et al., [@B21]), with significant effects on the regulation of fear and anxiety, stress responsiveness, and motivated behaviors observed in adult offspring (Romeo et al., [@B66]; Lee et al., [@B45]; Michaels et al., [@B53]; George et al., [@B29]; Skripuletz et al., [@B72]; Macri et al., [@B49]). Often, these effects are sex-specific (Slotten et al., [@B75]). It is not clear whether all of these alterations in offspring development are directly related to maternal behavior. It is certainly possible that a number of these effects are mediated by factors present in the milk (e.g., corticosterone or prolactin) or represent some interplay between maternal care, maternal endocrine milieu, and the offspring\'s own physiology. When considering how these findings might translate to human mothers and their infants, it is important to remember that there are significant developmental differences between rodents and humans. Indeed, neurodevelopment in the postnatal rat is comparable to that observed in second and third trimester infants (Bayer et al., [@B5]). By determining what mechanisms underlie changes in adult phenotype that are induced by alterations in maternal care, we may gain significant insight into how early life experience, both *in utero* and during the early postpartum period, may alter neurodevelopment. Overall, these findings on maternal care in rodents clearly indicate that even ostensibly modest changes in the postpartum environment can significantly impact offspring development.

How then might adolescent morphine exposure induce alterations in maternal care? One possible mechanism may be a shift in the endogenous opioid system. Indeed, we previously observed significant shifts in the regulation hypothalamic, opioid-related gene transcription following adolescent opioid exposure (Byrnes, [@B9]). These effects on gene transcription persisted for at least 10 weeks following cessation of morphine administration. Thus, a shift in endogenous opioid-mediated regulation of maternal behavior may be one consequence of adolescent morphine exposure.

The importance of endogenous opioids in both the pre- and postnatal period has been well documented. Opioids directly regulate numerous aspects of embryonic and fetal development (Kar and Quirion, [@B37]; Leslie et al., [@B47]; Zagon et al., [@B98]; Kivell et al., [@B42]; Cooney et al., [@B20]). Moreover, during pregnancy and parturition, endogenous opioids modulate both the maternal and fetal hypothalamic--pituitary--adrenal axis (Taylor et al., [@B81]; Douglas et al., [@B23]), and regulate maternal central oxytocin activity (Douglas et al., [@B22]; Douglas and Russell, [@B24]; Kutlu et al., [@B44]). The role of endogenous opioids in the regulation of specific aspects of maternal care in the rat is not well-defined. There is evidence, however, that the administration of an opioid antagonist increases the duration of nursing bouts and mother--offspring contact time during early lactation (Byrnes et al., [@B10]). These data fit well with the hypothesis that opioids regulate maternal--offspring attachment processes (Nelson and Panksepp, [@B57]; Weller and Feldman, [@B94]). Thus, in the face of opioid receptor blockade, the female may prolong contact and/or nursing bouts to achieve a similar level of reward associated with pup contact. In this context, one would postulate that MOR-F0 females may have more sensitive opioid receptors and therefore may terminate their nursing bouts sooner. While we observed significantly increased mu- and kappa-opioid receptor mRNA in non-lactating MOR-F0 females, no differences in the expression of these receptor subtypes were observed during lactation (Byrnes, [@B9]). Of course, protein expression and/or postsynaptic response of these receptors could be modified in MOR-F0 females. Moreover, our previous studies only examined changes in the mediobasal hypothalamus. Certainly, significant differences in opioid receptor number and/or function in any number of brain regions could underlie changes in nursing behavior during early lactation. This would not, however, explain the increased contact time (i.e., hovering) observed in MOR-F0 mother. Perhaps then, some other change in the female\'s behavior might underlie the observed effects on nursing frequency.

Examination of the differences in nursing behavior and contact time reveal a significant influence of both the time of day and the testing method. MOR-F0 females only spent more time away from the nest during the dark and these differences were only significant when tested using frequency data. Similarly, when recorded continuously, no decrease in the duration of nursing was observed during early lactation. One obvious difference between our frequency and duration data was the presence of an observer during frequency data collection. We have noticed that qualitatively, MOR-F0 females appear to be more sensitive to any disturbance in their environment. Thus, while all of our observations were conducted in the home cage, and care was taken not to disturb the female and her litter, MOR-F0 females would often come off the nest and rear up toward the front of the cage during the 30-min observation session. In addition, this behavioral pattern appeared more robust during the dark phase. Thus, the simple act of observing MOR-F0 females may have altered their nursing frequency. These effects would be more robust during early lactation when immature pups are unable to maintain nipple contact when the dam rears or changes positions. If a more general, non-specific, increase in "distractibility" underlies these changes in maternal care, this would suggest that MOR-F0 mothers may be more likely to decrease the care of their offspring in the presence of substantial environmental distracters.

The data on the duration of nursing suggests that during later postnatal time points, MOR-F0 mothers have more prolonged nursing bouts. As mentioned previously, during these later time points pups are more able to maintain nursing contact even when the female moves either within or even off of the nest. Thus, rearing up in the presence of any distracter would not be as detrimental to nursing when pups are older. However, this would not explain why the female nurses for longer periods when compared to SAL-F0 females. One possibility is that the female and/or offspring are compensating for decreased nutrition during early lactation with more sustained lactation during later development. Indeed, the bodyweight data demonstrate that MOR-F1 weanlings are heavier than their SAL-F1 counterparts. To what extent maternal nursing behavior, as opposed to some other metabolic factor, induces this difference in body weight is unknown. However, we have previous data suggesting differences in the lactogenic hormone prolactin in MOR-F1 mothers, with lower levels observed during early lactation and higher levels observed during late lactation (Byrnes, [@B8]). Thus, MOR-F0 females may not necessarily be deficient in their nursing behavior, but rather may demonstrate a shift in the developmental profile of this behavior over the course of lactation. Overall, these data suggest that subtle modifications in maternal care, especially relating to nursing and non-nursing contact, are a consequence of adolescent morphine exposure. To what extent these differences play a role in the behavioral phenotype of their offspring remains to be determined.

In addition to modifying maternal care, adolescent morphine exposure induced transgenerational effects on juvenile play behavior. MOR-F1 males demonstrated a significant reduction in rough and tumble play, with no change in other aspects of social behavior (social grooming or exploration). In addition, there was a trend toward increased rough and tumble play behavior in MOR-F1 females, although these effects did not achieve significance. Rough and tumble play is displayed by a wide-range of species and is an important developmental marker (Auger and Olesen, [@B3]; Auger et al., [@B2]). It has been suggested that low levels of rough and tumble play may indicate vulnerability toward reduced motivated behavior in adulthood (Trezza et al., [@B82]). For example, animal models have demonstrated a relationship between rough and tumble play and future sexual and aggressive behaviors (van den Berg et al., [@B84]; Cervantes et al., [@B14]; Wommack and Delville, [@B95]). Thus, decreased rough and tumble play in MOR-F1 males may suggest an increased risk for deficits in other motivated behavior in adulthood.

The neural systems underlying rough and tumble play have been fairly well elucidated (Gordon et al., [@B31]), with opioids playing a significant role in the regulation of this behavioral repertoire. Specifically, administration of morphine enhances play behavior, while administration of the mu-opiate receptor antagonist naloxone, reduces rough and tumble play (Panksepp et al., [@B61]; Vanderschuren et al., [@B87]; Guard et al., [@B32]; Trezza and Vanderschuren, [@B83]). Moreover, when juveniles are socially isolated, thereby eliminating all experiences of play, both mu and kappa receptors are significantly up-regulation in several nuclei related to emotional regulation (Van den Berg et al., [@B85]). Thus, the reduction in rough and tumble play behavior could be a symptom of a down-regulation of functional mu-opiate receptors in MOR-F1 males or conversely, their low levels of play could induce alterations in opiate receptors. In line with these data, previous findings in adult MOR-F1 males, demonstrate significant alterations in their response to opiates (Byrnes, [@B7]; Byrnes et al., [@B11]). Thus, one intriguing possibility is that MOR-F0 females transfer modifications in neural opioid systems to their offspring. The mechanism underlying this type of epigenetic effect is unknown, but could certainly involve alterations in maternal care or maternal endocrine milieu.

Finally, consideration of the current findings in the context of effects following prenatal morphine administration is warranted. Certainly, morphine exposure during the prenatal period has been shown to significantly impact offspring development (Sobrian, [@B76]; Vathy and Katay, [@B90]; Lesage et al., [@B46]; Vathy et al., [@B89]; Slamberova et al., [@B73]), with many of these effects involving changes in opioidergic function (O\'Callaghan and Holtzman, [@B60]; Ramsey et al., [@B64]; Gagin et al., [@B28]; Chiou et al., [@B17]; Villarreal et al., [@B92]). Interestingly, the effects we observed in MOR-F1 animals are in the opposite direction of those observed in the offspring of females exposed to morphine *in utero*, with rough and tumble play behavior found to be increased in the offspring of females exposed to morphine during gestation (Hol et al., [@B34]; Niesink et al., [@B58]). In fact, our effects are more similar to those observed following administration of opioid antagonists during fetal development (Shepanek et al., [@B70]; Medina Jimenez et al., [@B52]). Thus, the transgenerational effects observed in the offspring of adolescent morphine-exposed females may be indicative of a down-regulation of the endogenous opioid system in their mothers, perhaps both pre- and postnatally, which is then transmitted to their offspring via currently unidentified, epigenetic processes. Such processes could include modifications in maternal--offspring interactions.

Conclusion
==========

Adolescent use of prescription pain relievers has increased dramatically in the past decade, especially in young females. Beyond the risks of overdose or addiction, the long-term effects of exposure to such powerful opiates during a critical period of neurodevelopment are unknown. As endogenous opioids play such a significant role in reproductive function, prior opiate use could influence pre- and/or postnatal factors. Given the importance of opioids in maternal--offspring interactions, and the critical role that mothers play in the healthy development of their children, it is possible that opiate use in adolescent girls could have repercussions for future generations. To begin to elucidate the possible long-term effects of adolescent opiate use, animal models examining the impact of adolescent opiate exposure on both the female and her future offspring are required. The current findings demonstrate that exposure to increasing doses of morphine during adolescent development can induce subtle changes in maternal care and offspring development. While the neural and/or endocrine mechanisms underlying these effects remain to be determined, a shift in the endogenous opioid system of both mother and offspring seems likely. These findings strongly suggest that adolescent female opiate use, occurring prior to mating, and in the absence of any further use pre- or postnatally, can impact maternal--offspring interactions and the behavioral phenotype of their offspring. Thus, concerns about the impact of maternal drug use on children\'s health, should not only include consideration of *in utero* exposure, but prior drug history as well.
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